Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3241302 | 0.83 | THRB (0.38) | THRBTHRATSHRHPGDCYP1A2 | |
| SCHEMBL3248628 | 0.83 | THRA (0.44) | THRBTHRATSHRMMP1MMP9 | |
| SCHEMBL28036028 | 0.78 | EPHX1 (0.36) | THRBTHRATSHRHPGDCYP1A2 | |
| SCHEMBL1108008 | 0.78 | TSHR (0.43) | THRBTSHRHPGDCYP1A2ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL6720468 | 0.76 | TSHR (0.42) | THRBTSHRHPGDCYP1A2ALDH1A1 | |
| SCHEMBL676350 | 0.74 | EPHX1 (0.33) | THRBTHRA | |
| SCHEMBL14509314 | 0.74 | THRB (0.38) | THRBTSHRHPGDALDH1A1 | |
| SCHEMBL20579982 | 0.74 | LMNA (0.33) | THRB | |
| SCHEMBL8408097 | 0.73 | THRB (0.35) | THRBTHRATSHRHPGDALDH1A1 | |
| SCHEMBL9610295 | 0.72 | THRA (0.33) | THRBTHRATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7745658-B2 | Process for preparing tertiary alkyl esters of (meth)acrylic acid having at least 4 carbon atoms in the alkyl radical | BASF SE (DE) | 2010-06-29 | — | — | US | disclosed |
| US-20090023947-A1 | PROCESS FOR PREPARING TERTIARY ALKYL ESTERS OF (METH) ACRYLIC ACID HAVING AT LEAST 4 CARBON ATOMS IN THE ALKYL RADICAL | BASF SE (DE) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023947-A1 | PROCESS FOR PREPARING TERTIARY ALKYL ESTERS OF (METH) ACRYLIC ACID HAVING AT LEAST 4 CARBON ATOMS IN THE ALKYL RADICAL | ACSL3, ACSL1, ACSL4 | THRB 1523/4885THRA 347/4885TSHR 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.